Highland Capital Management (Texas)’s Viking Therapeutics VKTX Stock Holding History

Highland Capital Management (Texas)’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$851K	Hold	102,492	–	–	0.05%	220
2019 Q1	$1.02M	Hold	102,492	–	–	0.06%	204
2018 Q4	$784K	Buy	102,492 +75,000	+273%	+$897K	0.06%	175
2018 Q3	$479K	Sell	27,492 -4,300	-14%	-$51.2K	0.03%	227
2018 Q2	$302K	Buy	+31,792	New	+$211K	0.02%	271

Other funds holding VKTX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Highland Capital Management (Texas)'s VKTX Position: Q2 2019 in Review

Highland Capital Management (Texas) held its Viking Therapeutics (VKTX) position steady in Q2 2019 at 102,492 shares worth $851K. The position accounts for 0.05% of the portfolio, ranked #220.

Highland Capital Management (Texas) first reported a position in VKTX in Q2 2018 and has held it in 5 quarters since. The position peaked at $1.02M in Q1 2019. 156 funds tracked by Wall St. Rank hold VKTX as of Q2 2019.

Highland Capital Management (Texas) held 102,492 shares of Viking Therapeutics worth $851K as of Q2 2019.
Highland Capital Management (Texas) left its Viking Therapeutics share count unchanged in Q2 2019.
Viking Therapeutics made up 0.05% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #220 holding.
Highland Capital Management (Texas) first reported a position in Viking Therapeutics in Q2 2018 and has held it in 5 quarters since.
Highland Capital Management (Texas)'s Viking Therapeutics position peaked at $1.02M in Q1 2019.
156 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.